Funding for this research was provided by:
National Key Research and Development Program of China (2018YFE0114100)
Key Technology Research and Development Program of Shandong (2019GGX101057)
Science Technology Program of Jinan (201805051)
Received: 31 January 2021
Accepted: 10 May 2021
First Online: 7 June 2021
: The trial was registered with Chinese Clinical Trial Registry (ChiCTR2100046106). This study was approved by the institutional review board of Shandong Cancer Hospital and Institute. All patients provided written informed consent to participate in the study.
: Not applicable.
: The authors declare that they have no competing interests.